Pain Brake

Washington University School of Medicine researchers discovered that μ-opioid receptors (MORs)on neurons in the brain's locus coeruleus act as a biological brake on chronic neuropathic pain — published August 17 in Current Biology. Mice lacking these receptors became hypersensitive to touch and heat; restoring them reversed the pain entirely. The goal: targeted LC-specific therapies that deliver relief without systemic opioid side effects.

pain sensitivity: 95%
Brain region
Locus Coeruleus
noradrenaline hub
Receptor
μ-Opioid (MOR)
the brake
MOR absent
Hypersensitivity
allodynia + hyperalgesia
MOR restored
Pain reversed
re-expression rescue
Signal type
Descending NE
LC → dorsal horn
Published
Aug 17 2026
Current Biology
Institution
WashU Medicine
St. Louis
Pain model
Neuropathic
nerve injury (mice)
Pain circuit → brake pathway

Why this matters: Current opioid drugs act broadly across the brain and body, causing addiction, sedation, and respiratory depression. The locus coeruleus MOR brake is anatomically specific — targeted delivery to LC-resident MORs could interrupt the chronic pain loop without engaging reward circuits or peripheral opioid receptors.

The LC sends noradrenergic projections down to the dorsal horn of the spinal cord, modulating how incoming pain signals are gated. Without MOR brakes, the LC fires in a sustained high-activity state that amplifies central sensitization — the same mechanism underlying fibromyalgia and phantom limb pain.